Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > The GMP Letter > WLF Criticizes FDA's Warning Letter System

The GMP Letter

November 2006

WLF Criticizes FDA's Warning Letter System

The FDA's warning letter system is flawed and must be revised, according to a report released by the Washington Legal Foundation (WLF).

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Related Articles

Study: Computer-Aided Mammography Less Accurate Integrity and Accountability Warrant New Office Within U.S. FDA CDER to Require eCTD Format for Electronic Submissions New Call for UK to Reform First-in-Man Clinical Trials

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.